South Staffordshire Joint FormularyCannock Chase Clinical Commissioning Group East Staffordshire Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group
Preservative-free (PF) formulations - Preservative intolerance should be diagnosed by an ophthalmologist. If PF formulation is warranted, proprietary preservative-free formulations (often available as unit dose preparations) should be prescribed if at all possible. Manufactured “specials” are unlicensed and almost invariably cost significantly more. PF formulations are appropriate, for example when a patient wears soft contact lenses or daily disposable contact lenses and wearing glasses instead is not a viable option such as for long courses OR where patient shows signs of preservative toxicity sometimes seen with multiple daily administrations.
Details...
11.04.02
Other anti-inflammatory preparations
Sodium Cromoglicate
First Choice
Sod Cromoglicate_Eye Dps 2%
Antazoline 0.5% with Xylometazoline 0.05% (Otrivine-Antistin®)
Formulary
Otrivine-Antistin_Eye Drops
Self Care Medicine-Available OTC for self-care
Nedocromil (Rapitil®)
Formulary
Nedocromil Sod_Eye Dps Aq 2%
DISCONTINUED 2018
Olopatadine (Opatanol®)
Formulary
Olopatadine_Eye Dps 1mg/ml
....
Non Formulary Items
Azelastine (Optilast®)
Non Formulary
Emedastine (Emadine®)
Non Formulary
Epinastine (Relestat®)
Non Formulary
Ketotifen (Zaditen®)
Non Formulary
Lodoxamide (Alomide®)
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.
Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)
Suitable first-line drugs for implementation in Primary Care